Glutamine metabolism inhibition-related targets and clinical research Glutamine transporter inhibitors As the mechanism of glutamine metabolism in the TME has been continuously explored and revealed, the potential of its related targets in tumor treatment has also received clinical attention
has served as a consultant to 89bio, Aardvark Therapeutics, Altimmune, Arrowhead Pharmaceuticals, AstraZeneca, Cascade Pharmaceuticals, Eli Lilly, Gilead, Glympse Bio, Inipharma, Intercept, Inventiva, Ionis, Janssen, Lipidio, Madrigal, Neurobo, Novo Nordisk, Merck, Pfizer, Sagimet, Takeda, Terns Pharmaceuticals and Viking Therapeutics
10.1097/WNF.0000000000000170 74
Greek yogurt cups can be grabbed from the fridge in seconds
Thats precisely the role of BAC Water, or bacteriostatic water, in medical settings
Tacrolimus loaded cationic liposomes for dry eye treatment